Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine

Psychiatry Res. 2007 Dec 15;156(3):251-5. doi: 10.1016/j.pscychresns.2007.05.002. Epub 2007 Nov 13.

Abstract

Prefrontal repetitive transcranial magnetic stimulation (rTMS) has been shown to increase striatal dopaminergic activity. Here we investigated dopaminergic neurotransmission using single photon emission computed tomography (SPECT) and [(123)I]IBZM to indirectly assess the change in endogenous striatal dopamine concentration upon rTMS as compared with d-amphetamine challenge. SPECT imaging was performed twice each in five patients during rTMS, and in two patients who received 0.3 mg/kg D-amphetamine. Administration of rTMS led to a mean relative decrease in striatal IBZM binding by 9.6+/-6.2%, and d-amphetamine challenge (n=4) induced a mean relative reduction by 8+/-2.95% (difference not statistically significant). Acute rTMS challenge showed similar striatal dopaminergic effects to those associated with the administration of d-amphetamine, a substance known to increase synaptic dopamine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / pharmacology*
  • Corpus Striatum / metabolism*
  • Depressive Disorder, Major / therapy*
  • Dextroamphetamine / administration & dosage
  • Dextroamphetamine / pharmacology*
  • Female
  • Humans
  • Injections, Intravenous
  • Iodine Radioisotopes
  • Male
  • Middle Aged
  • Prefrontal Cortex / metabolism*
  • Pyrrolidines
  • Tomography, Emission-Computed, Single-Photon
  • Transcranial Magnetic Stimulation / methods*

Substances

  • Benzamides
  • Central Nervous System Stimulants
  • Iodine Radioisotopes
  • Pyrrolidines
  • 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
  • Dextroamphetamine